Programs

Empowering Oncology Clinical Research Site Success

The SCRS Oncology Program empowers clinical research sites as essential partners in the cancer research ecosystem. Through targeted resources, advocacy, and collaboration opportunities, the program helps sites overcome complex operational challenges while strengthening relationships between sites, pharmaceutical companies, and patients. 

 

Built for Oncology’s Complexity. Driven by the Site Voice.

Oncology trials carry a level of operational and scientific complexity general site resources don’t address. The SCRS Oncology Program unites sites, CROs, sponsors, and solution providers to tackle it together. Through industry alliances, hands-on networking, targeted education, and standardized assessment of sponsor and CRO partnerships, the program strengthens site sustainability and improves patient access to cancer trials. 

Forty percent of sites spend up to 15 hours per month per trial on technology training alone, and a quarter of sites are spending up to 20 hours or more. 

0
%
Completion rate

Compared to 80% completion rate for non-oncology and 49% completion for rare disease trials.

*2025 SCRS Site Landscape Survey

Program Goals

1

Advance oncology site capabilities through resources, best practices, and peer connections worldwide.

2

Foster sponsor & CRO partnerships that drive innovation and improve trial execution across the oncology landscape.

3

Support emerging sites by building the infrastructure and expertise to participate confidently in clinical research.

4

Drive data-informed progress using insights from our global network to identify trends and guide strategic decisions.

Best Practices & Oncology Resources for Sites

Phase 1 Oncology Trial Guide

The SCRS Oncology Education Committee developed a resource to guide sites that wish to expand their offerings into Phase 1 clinical trials. This document outlines several major considerations sites should explore when considering Phase 1 oncology trials.

RECIST Training Modules

Clinical research training courses were created to support site understanding of response evaluation criteria in solid tumors (RECIST1) and response evaluation criteria in clinical trials with immunotherapies (iRECIST2).

Site Strategies for Inclusive Oncology Trials

The 2025 Site Strategies for Inclusive Oncology Trials Survey reveals critical challenges faced by oncology research sites in fostering greater inclusivity and access within cancer clinical trials. Download the full white paper to gain valuable insights on evidence-based strategies to overcome recruitment barriers, enhance community outreach, and advance health equity in cancer research.

Webinars

Unveiling Hidden Costs: Empowering Oncology Sites For Trial Success

This webinar uses the SCRS Site Invoiceables Toolkit to highlight billable items often missed in oncology trial budgets. Learn how to negotiate budgets effectively and keep your site financially sustainable. Watch Now

Entering Oncology Trials

This webinar covers what sites need to succeed in oncology research, from regulatory and ethical considerations to infrastructure, staffing, and patient recruitment. Get the practical insights to prepare your site for successful trial participation. Watch Now

Oncology Spirit Partners

Participating Sites

SCRS Oncology Program Leadership

Jolee Holt

Oncology Program Board Chair

Connect with Jolee

Email Jolee

Kathy Busto Mickel

Vice President, Membership & Education

Connect with Kathy

Email Kathy

Lauren Stockwell

Associate Director, Education & Engagement

Connect with Lauren

Email Lauren

Ready to Make Your Mark?

Your experience matters. Join an SCRS committee and put your expertise to work and help to strengthen clinical research sites worldwide and driving meaningful change across the industry.